Lactiplantibacillus plantarum
SN13T is a probiotic plant-derived lactic
acid bacterium that can grow in various medicinal plant extracts. In this study, we
fermented an aqueous extract of gardenia fructus, the fruit of a medicinal plant, with
SN13T, such that the bioactivity of the extract was potentiated after fermentation to
suppress the release of inflammatory mediators, such as nitric oxide (NO), reactive oxygen
species (ROS), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), as well as
downregulate inflammatory genes in lipopolysaccharides (LPS)-stimulated RAW 264.7 cells.
This increased antioxidant and anti-inflammatory activity was mediated through
bioconversion of the iridoid glycoside geniposide to its aglycone genipin via the supposed
hydrolytic action of β-glucosidases harbored by SN13T. In the complete genome of SN13T,
ten putative genes encoding β-glucosidases of glycosyl hydrolase (GH) family 1 organized
among eight gene operons were identified. Transcriptional profiling revealed that two
6-phospho-β-glucosidase genes,
pbg9
and
SN13T_1925
,
located adjacently in the gene operon
SN13T_1923
, were transcribed
significantly more than the remaining genes during fermentation of the gardenia extract.
This suggests the role of these β-glucosidases in bioconversion of geniposide to genipin
and the subsequent enhanced bioactivity of the gardenia fructus extract after fermentation
with SN13T.